Literature DB >> 7882908

Intracellular distribution of lysozyme in rat alveolar type II epithelial cells.

K F Gibson1, S Phadke.   

Abstract

This study investigated the intracellular distribution of lysozyme, a protein that is synthesized and secreted by rat alveolar type II epithelial (ATII) cells and alveolar macrophages, using a polyclonal antibody generated against purified rat lysozyme. Lysozyme was immunoprecipitated with this antibody from Triton X-100 lysates of ATII cells cultured on a basement membrane derived from Englebreth-Holme-Swarm mouse sarcoma (EHS) and radiolabeled with 35S-methionine. ATII cells cultured on EHS basement membrane for several days were fixed and labeled with antibodies to surfactant apoprotein A (SP-A) and lgp-120 (a lysosomal glycoprotein), or lysozyme and lgp-120, and studied by confocal microscopy. Organelles were identified that stained positively for either anti-lysozyme or anti-lgp-120; a second population of organelles contained both markers. Similarly, two populations of SP-A-containing organelles were identified; one contained the lysosomal glycoprotein lgp-120. In addition, confocal images demonstrated that both SP-A and lysozyme were secreted by ATII cells, as evidenced by the accumulation of secretory products within the lumen of the cyst-like aggregates. When the subcellular localization of SP-A and lysozyme was studied by analytical cell fractionation, two populations of organelles were identified that contained SP-A or lysozyme. The lighter population accounted for approximately 32% of SP-A and 33% of total intracellular lysozyme and was recovered in the same region of the gradient as secretory lamellar bodies. The more dense population co-localized with lysosomes and accounted for approximately 67% of both SP-A and lysozyme recovered. Western blots of cell fractions revealed intact lysozyme in all the cell fractions. The results of these experiments suggest that lysozyme has a similar intracellular distribution as surfactant apoprotein A in ATII cells. Lysozyme is found in fractions containing lamellar bodies where it is packaged for secretion, and in lysosomal fractions where it may undergo degradation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7882908     DOI: 10.3109/01902149409031739

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  4 in total

1.  Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins.

Authors:  H P Jia; J N Mills; F Barahmand-Pour; D Nishimura; R K Mallampali; G Wang; K Wiles; B F Tack; C L Bevins; P B McCray
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Lower respiratory tract delivery, airway clearance, and preclinical efficacy of inhaled GM-CSF in a postinfluenza pneumococcal pneumonia model.

Authors:  Todd M Umstead; Eranda Kurundu Hewage; Margaret Mathewson; Sarah Beaudoin; Zissis C Chroneos; Ming Wang; E Scott Halstead
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-29       Impact factor: 5.464

3.  Interleukin-13 disrupts type 2 pneumocyte stem cell activity.

Authors:  Kristen M Glisinski; Adam J Schlobohm; Sarah V Paramore; Anastasiya Birukova; M Arthur Moseley; Matthew W Foster; Christina E Barkauskas
Journal:  JCI Insight       Date:  2020-01-16

Review 4.  Alveolar epithelial type II cell: defender of the alveolus revisited.

Authors:  H Fehrenbach
Journal:  Respir Res       Date:  2001-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.